"Stevens-Johnson Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
Descriptor ID |
D013262
|
MeSH Number(s) |
C07.465.864.500 C17.800.174.600.900 C17.800.229.400.683 C17.800.865.475.683 C20.543.206.380.900 C25.100.468.380.900
|
Concept/Terms |
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum- Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
- Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
- Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum
- Toxic Epidermal Necrolysis Stevens Johnson Syndrome
- Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum
- Toxic Epidermal Necrolysis Stevens-Johnson Syndrome
- Stevens Johnson Syndrome Toxic Epidermal Necrolysis
- Stevens-Johnson Syndrome Toxic Epidermal Necrolysis
Mycoplasma-Induced Stevens-Johnson Syndrome- Mycoplasma-Induced Stevens-Johnson Syndrome
- Mycoplasma Induced Stevens Johnson Syndrome
- Stevens-Johnson Syndrome, Mycoplasma-Induced
- Syndrome, Mycoplasma-Induced Stevens-Johnson
- Mycoplasma-Induced Stevens Johnson Syndrome
Drug-Induced Stevens Johnson Syndrome- Drug-Induced Stevens Johnson Syndrome
- Drug Induced Stevens Johnson Syndrome
- Drug-Induced Stevens-Johnson Syndrome
- Drug-Induced Stevens-Johnson Syndromes
- Stevens-Johnson Syndrome, Drug-Induced
- Stevens-Johnson Syndromes, Drug-Induced
Epidermal Necrolysis, Toxic- Epidermal Necrolysis, Toxic
- Epidermal Necrolyses, Toxic
- Necrolyses, Toxic Epidermal
- Necrolysis, Toxic Epidermal
- Toxic Epidermal Necrolyses
- Toxic Epidermal Necrolysis
- Scalded Skin Syndrome, Nonstaphylococcal
- Lyell's Syndrome
- Lyell Syndrome
- Lyell's Syndromes
- Syndrome, Lyell's
- Syndromes, Lyell's
- Nonstaphylococcal Scalded Skin Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Stevens-Johnson Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Stevens-Johnson Syndrome".
This graph shows the total number of publications written about "Stevens-Johnson Syndrome" by people in this website by year, and whether "Stevens-Johnson Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 10 | 4 | 14 |
2018 | 11 | 1 | 12 |
2019 | 4 | 0 | 4 |
2020 | 0 | 1 | 1 |
2021 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Stevens-Johnson Syndrome" by people in Profiles.
-
Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review. Int J Clin Pract. 2021 Dec; 75(12):e14720.
-
COVID-19 vaccine-induced Stevens-Johnson syndrome. Clin Exp Dermatol. 2021 Dec; 46(8):1615-1617.
-
Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 10; 132(4):e139-e142.
-
Corona virus disease 2019-associated Stevens-Johnson syndrome: a case report. BMC Ophthalmol. 2021 Jul 12; 21(1):274.
-
Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic. Adv Emerg Nurs J. 2021 Jul-Sep 01; 43(3):194-197.
-
Case of erythema multiforme/Stevens-Johnson syndrome: an unusual presentation of COVID-19. J R Coll Physicians Edinb. 2021 06; 51(2):160-161.
-
Toxic epidermal necrolysis and role of immune dysregulation in a patient affected by coronavirus disease. Ital J Dermatol Venerol. 2021 Aug; 156(4):498-499.
-
COVID-19-induced toxic epidermal necrolysis. Clin Exp Dermatol. 2021 07; 46(5):927-929.
-
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1099-1107.
-
Development of toxic epidermal necrolysis in a coronavirus disease 2019 patient with recurrence of positive SARS-CoV-2 viral RNA. J Dermatol. 2021 Mar; 48(3):e144-e145.